EC Number |
Inhibitors |
Structure |
---|
1.5.1.2 | ([[(3,5-dibromophenyl)methyl]amino]methylene)bis(phosphonic acid) |
competitive inhibition against both 1-pyrroline 5-carboxylate and NADPH. Growth of myelogenous erythroleukemic K562 and epithelial breast cancer MDA-MB-231 cell lines is progressively impaired by concentrations ranging from 1-100 microM |
|
1.5.1.2 | ([[(3,5-dichlorophenyl)methyl]amino]methylene)bis(phosphonic acid) |
competitive inhibition against both 1-pyrroline 5-carboxylate and NADPH |
|
1.5.1.2 | ([[3,5-bis(trifluoromethyl)phenyl]amino]methanediyl)bis(phosphonic acid) |
71.2% inhibition at 0.2 mM |
|
1.5.1.2 | 2,3-dichlorophenylhydroxymethylenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(2,3-dichlorophenyl)-1-hydroxyethylidenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(2,3-dichlorophenylamino)ethylidenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(2,6-dichlorophenyl)-1-hydroxyethylidenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(2,6-dichlorophenylamino)ethylidenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(3,5-di(trifluoromethyl)phenylamino)ethylidenebisphosphonic acid |
- |
|
1.5.1.2 | 2-(3,5-dichlorophenylamino)ethylidenebisphosphonic acid |
- |
|